Pathophysiology and pharmacology of GABAA receptors

Handbook of Experimental Pharmacology

Volumn 169, Issue , 2005, Pages 225-247

  Mohler H ^a,b,c   Fritschy, J M ^a   Vogt, K ^a   Crestani, F ^a   Rudolph, U ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c Swiss Federal Institute of Technology Collegium Helveticum   (Switzerland)

Author keywords

Anxiolytics; Epilepsy; Hypnotics; Memory; Schizophrenia

Indexed keywords

EID: 85099486294     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-28082-0_9     Document Type: Article

References (134)

1. Alger BE, Pitler TA (1995) Retrograde signaling at GABAA-receptor synapses in the mammalian CNS. Trends Neurosci 18:333-340
2. Barnard EA, SkolnickP, OlsenRW, Möhler H, SieghartW, Biggio G, Braestrup C, Bateson AN, Langer SZ (1998) Subtypes of ?-aminobutyric acidAreceptors: classification on the bases of subunit structure and receptor function. Pharmacol Rev 50:291-313
3. Baulac S, Huberfeld G, Gourfinkel-An I, Mitropoulou G, Beranger A, Prudhomme JF, Baulac M, Brice A, Bruzzone R, LeGuern E (2001) First genetic evidence of GABAA receptor dysfunction in epilepsy:amutation in the ?2-subunit gene. Nat Genet 28:46-48
4. Bianchi MT, Song L, Zhang H, Macdonald RL (2002) Two different mechanisms of disinhibition produced by GABAA receptormutations linked to epilepsy in humans. J Neurosci 22:5321-5327
5. Bohlhalter S, WeinmannO, Möhler H, Fritschy JM (1996) Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study. JNeurosci 16:283-297
6. Bormann J (2000) The "ABC" of GABA receptors. Trends Pharmacol Sci 21:16-19
7. BouilleretV, RidouxV, Depaulis A, Marescaux C, NehligA, LeGal La SalleG (1999) Recurrent seizures and hippocampal sclerosis following intrahippocampal kainite injectionin adult mice: EEG, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 89:7171-7729
8. Bouilleret V, Loup F, Kiener T, Marescaux C, Fritschy JM (2000) Early loss of interneurons and delayed subunit-specific changes in GABAA-receptor expression in a mouse model of mesial temporal lobe epilepsy. Hippocampus 10:305-324
9. Brickley SG, Cull-Candy SG, Farrant M (1996) Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J Physiol 497:753-759
10. Brickley SG, Revilla V, Cull-Candy SG, WisdenW, Farrant M (2001) Adaptive regulation of neuronal excitability by a voltage independent potassiumconductance.Nature 409:88-92
11. Brun VH, Otnaess MK, Molden S, Steffenach HA, Witter MP, Moser MB, Moser EI (2002) Place cells and place recognition maintained by direct entorhinal-hippocampal circuitry. Science 296:2243-2246
12. Brussaard AB, Herbison AE (2000) Long-term plasticity of postsynaptic GABAA-receptor function in the adult brain: insights from the oxytocin neurone. Trends Neurosci 23:190-195
13. Buhl EH, Tamas G, Fisahn A (1998) Cholinergic activation and tonic excitation induce persistent gamma oscillations in mouse somatosensory cortex in vitro. J Physiol (Lond) 513:117-126
14. Burgess N, Maguire EA, OKeefe J (2002) The human hippocampus and spatial and episodic memory. Neuron 35:625-641
15. BuzsakiG, Chrobak JJ (1995) Temporal structure in spatially organized neuronal ensembles: a role for interneuronal networks. Curr Opin Neurobiol 5:504-510
16. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, CarlssonML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260
17. CaulfieldMP, BrownDA (1992) Cannabinoid receptor agonists inhibit Ca current in NG108- 15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol 106:231-232
18. Chambers MS, attack JR, Broughton HB, Collinson N, Cook S, Dawson GR, Hobbs SC, Marshall G, Maubach KA, Pillai GV, Reeve AJ, MacLeod AM (2003) Identification of a novel, selective GABAA ?5 receptor inverse agonist which enhances cognition. J Med Chem 46:2227-2240
19. Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability [comment]. Neuron 38:461-472
20. Cohen I, Navarro V, Clemenceau S, Baulac M, Miles R (2002) On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298:1418-1421
21. Collinson N (2002) Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the ?5 subunit of the GABAA receptor. J Neurosci 22:5572-5580
22. Cossette P, Liu L, Brisebois K, Dong H, Lortie A, Vanasse M, Saint-Hilaire JM, Carmant L, Verner A, Lu WY, Wang YT, Rouleau GA (2002) Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 31:184-189
23. Coulter DA (2001) Epilepsy-associated plasticity in ?-aminobutyric acid receptor expression, function, and inhibitory synaptic properties. Int Rev Neurobiol 45:237-252
24. Crestani F, LorezM, Baer K, EssrichC, BenkeD, Laurent JP, Belzung C, Fritschy JM, LuscherB, Möhler H (1999) Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 2:833-839
25. Crestani F, Martin JR, Möhler H, Rudolph U (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131:1251-1254
26. Crestani F, Löw K, Keist R, Mandelli M, Möhler H, Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442-445
27. Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Bluethmann H, Möhler H, Rudolph U (2002) Trace fear conditioning involves hippocampal ?5 GABAA receptors. Proc Natl Acad Sci U S A 99:8980-8985
28. Csicsvari J, Hirase H, Czurko A, Mamiya A, Buzsaki G (1999) Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving rat. J Neurosci 19:274-287
29. Dämgen K, Lüddens H (1999) Zaleplon displays a selectivity to recombinant GABAA receptors different from zolpidem, zopiclone and benzodiazepines. Neurosci Res Commun 25:139-148
30. Davis S, Butcher SP, Morris RGM (1992) The NMDA receptor antagonist D-2-amino-5- phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci 12:21-34
31. Devor A, Fritschy JM, Yarom Y (2001) Synaptic and extrasynaptic GABAA receptors in the inferior olivary nucleus differ in their spatial distribution, desensitization kinetics and subunit composition. J Neurophysiol 85:1686-1696
32. Engel AK, Fries P, Singer W (2001) Dynamic predictions: oscillations and synchrony in top-down processing. Nat Rev Neurosci 2:704-716
33. Eysenck MW (1992) The nature of anxiety. In: Gale A, Eysenck MW (eds) Handbook of individual differences: biological perspectives.Wiley and Sons, New York, pp 157-178
34. Fisahn A, Pike FG, Buhl EH, Paulsen O (1998) Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro. Nature 394:186-189
35. Freund TF, Buzsaki G (1996) Interneurons of the hippocampus. Hippocampus 6:345-470
36. Fritschy JM, Brünig I (2003) Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther 98:299-323
37. Fritschy JM, Möhler H (1995) GABAA receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359:154-194
38. Fritschy JM, Weinmann O, Wenzel A, Benke D (1998a) Synapse-specific localization of NMDA and GABAA receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol 390:194-210
39. Fritschy JM, Johnson DK, Möhler H, Rudolph U (1998b) Independent assembly and subcellular targeting of GABAA receptor subtypes demonstrated in mouse hippocampal and olfactory neurons in vivo. Neurosci Lett 249:99-102
40. Fritschy JM, Crestani F, Rudolph U, Möhler H (2004) GABAA receptor subtypes with special reference to memory function and neurological disorders. In: Hensch T (ed) Excitatory inhibitory balance: synapses, circuits and systems plasticity. Kluver Academic Press, pp 215-228
41. GaoB, Fritschy JM, BenkeD, MöhlerH (1993) Neuron-specific expressionofGABAA receptor subtypes: differential associations of the ?1- and ?3-subunits with serotonergic and GABAergic neurons. Neuroscience 54:881-892
42. Geiger JR, Lubke J, Roth A, Frotscher M, Jonas P (1997) Submillisecond AMPA receptormediated signalling at a principal neuron-interneuron synapse. Neuron 18:1009-1023
43. Gingrich KJ, RobertsWA, Kass RS (1995) Dependence of theGABAA receptor gating kinetics on the ?-subunit isoform: implications for structure-function relations and synaptic transmission. J Physiol 489:529-543
44. Goddard AW, Mason GF, Almai A, Rothman DL, Behar KL, Petroff OA, Chamey DS, Krystal JH (2001) Reductions in occipital cortex GABA levels in panic disorder detected 1H MRS. Arch Gen Psychiatry 58:556-561
45. Gulledge AT, Stuart GJ (2003) Excitatory actions of GABA in the cortex. Neuron 37:299-309
46. Gupta A, Wang Y, Markam H (2000) Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science 287:273-278
47. Harris KD, Henze DA, Hirase H, Leinekugel X, Dragoi G, Czurko A, Buzsaki G (2002) Spike train dynamics predicts theta-related phase precession in hippocampal pyramidal cells. Nature 417:738-741
48. Hood SD, Argyropoulos SV, Nutt DJ (2000) Agents in development for anxiety disorders. Current status and future potential. CNS Drugs 13:421-431
49. Huerta PT, Sun LD, Wilson MA, Tonegawa S (2000) Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons. Neuron 25:473-480
50. Huntsman MM, Tran BV, Potkin SG, Bunney Wejr, Jones EG (1998) Altered ratios of alternatively spliced ?2 subunit of mRNAs of GABAA receptors in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A 95:15066-15071
51. HuntsmannMM, PorcelloDM, Homanics GE, DeLorey TM, Huguenard JR (1999) Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 283:541-543
52. Hutcheon B, Morley P, Poulter MO (2000) Developmental change in GABAA receptor desensitization kinetics and its role in synapse function in rat cortical neurons. J Physiol 522:3-17
53. Jüttner R, Meier J, Grantyn R (2001) Slow IPSC kinetics, low levels of ?1 subunit expression and paired-pulse depression are distinct properties of neonatal inhibitory GABAergic synaptic connections in the mouse superior colliculus. Eur J Neurosci 13:2088-2098
54. Kalueff A, Nutt DJ (1997) Role of GABA inmemory and anxiety. Depress Anxiety 4:100-110
55. KananuraC, HaugK, SanderT, RungeU, GuW, HallmannK, RebstockJ, HeilsA, SteinleinOK (2002) A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 59:1137-1141
56. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, PalmeryM, Cuomo V, Piomelli D (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76-81
57. Katona I, Sperlagh B, Sik A, Käfalvi A, Vizi ES, Mackie K, Freund TF (1999) Presynaptically locatedCB1 cannabinoid receptors regulateGABArelease fromaxon terminals of specific hippocampal interneurons. J Neurosci 19:4544-4558
58. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF (2001) Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21:9506-9518
59. Klausberger T, Roberts JD, Somogyi P (2002) Cell type- and input-specific differences in the number and subtypes of synaptic GABAA receptors in the hippocampus. J Neurosci 22:2513-2521
60. Klausberger T, Magill PJ, Marton LF, Roberts JDB, Cobden PM, Buzsaki G, Somogyi P (2003) Brain state-and cell type-specific firing of hippocampal interneurons in vivo. Nature 421:844-848
61. Kreitzer AC, Regehr WG (2001a) Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells [comment].Neuron 29:717-727
62. Kreitzer AC, RegehrWG (2001b) Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 21:RC174
63. Langer SZ, Faure-Halley C, Seeburg P, GrahamD, Arbilla S (1992) The selectivity of zolpidem and alpidem for the ?1-subunit of the GABAA receptor. Eur Neuropsychopharmacol 2:232-234
64. Laurent G (1996) Dynamical representation of odors by oscillating and evolving neural assemblies. Trends Neurosci 19:489-496
65. Llano I, Leresche N, Marty A (1991) Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron 6:565-574
66. Loup F, WieserHG, YonekawaY, Aguzzi A, Fritschy JM (2000) Selective alterations inGABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 20:5401-5419
67. Löw K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Möhler H, RudolphU (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131-134
68. Maccaferri G, Roberts JDB, Szucs P, Cottingham CA, Somogyi P (2000) Cell surface domain specific postsynaptic currents evoked by identified GABAergic neurons in rat hippocampus in vitro. J Physiol 524:91-116
69. Maejima T, Ohno-Shosaku T, Kano M (2001) Endogenous cannabinoid mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29:729-738
70. Malizia AL (1999) What do brain imaging studies tell us about anxiety disorders? J Psychopharmacol 13:372-378
71. Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ (1998) Decreased brain GABAA-benzodiazepine receptor binding in panic disorders: preliminary results from a quantitative PET study. Arch Gen Psychiatry 55:715-720
72. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, ZieglgansbergerW, DiMarzoV, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-534
73. Martina M, Schultz JH, Ehmke H, Monyer H, Jonas P (1998) Functional and molecular differences between voltage-gated K+ channels of fast-spiking interneurons and pyramidal neurons of rat hippocampus. J Neurosci 18:1811-1825
74. McCormick DA, Bal T (1997) Sleep and arousal: thalamocortical mechanisms. Annu Rev Neurosci 20:185-215
75. McDonald BJ, Amato A, Connolly CN, BenkeD, Moss SJ, SmartTG (1998) Adjacent phosphorylation sites on GABAA receptor β subunits determine regulation by cAMP-dependent protein kinase. Nat Neurosci 1:23-28
76. McHugh TJ, Blum KI, Tsien JZ, Tonegawa S, Wilson MA (1996) Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell 87:1339-1349
77. McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor ?1 subtype. Nat Neurosci 3:587-592
78. Meldrum BS, Whiting P (2001) Anticonvulsants acting on the GABA system. In: Möhler H (ed) Pharmacology of GABA and glycine neurotransmission. Springer-Verlag, Berlin, Heidelberg, New York, pp 173-194
79. Metha MR, Lee AK, Wilson MA (2002) Role of experience and oscillations in transforming a rate code into a temporal code. Nature 417:741-746
80. Miles R (2000) Perspectives: neurobiology. Diversity in inhibition. Science 287:244-246
81. Minassian BA, DeLorey TM, Olsen RW, Philippart M, Bronstein Y, Zhang Q, Guerrini R, Van Ness P, Livet MO, Delgado-Escueta AV (1998) Angelman syndrome: correlations between epilepsy phenotypes and genotypes. Ann Neurol 43:485-493
82. Mody I, Nusser Z (2000) Differential activation of synaptic and extrasynaptic GABAA receptors. Eur J Neurosci 12 Suppl 11:398
83. Möhler H (2001) Functions of GABA receptors: pharmacology and pathophysiology. In: MöhlerH (ed) Pharmacology of GABA and glycine neurotransmission. Springer-Verlag, Berlin, Heidelberg, New York, pp 101-116
84. Möhler H (2002) Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology. DialoguesClinNeurosci 4:261-269 (this reference served as major source for the present article)
85. Möhler H, Benke D, Fritschy JM, Benson J 2000 The benzodiazepine site of GABAA receptors. Martin DL, Olsen RW (eds) ABA in the nervous system: the view at fifty years. Lippincott, Philadelphia. 97-112
86. Möhler H, Fritschy JM, RudolphU (2002) Anewbenzodiazepine pharmacology. JPharmacol Exp Ther 300:2-8 (This reference served as major source for the present article) MorrisRGM (1989) Synaptic plasticity and learning: selective impairment of learning in rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci 9:3040-3057
87. Morris RGM, Anderson A, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-termpotentiation by anN-methyl-D-aspartate receptor antagonist AP5. Nature 319:774-776
88. Moss SJ, Smart TG (2001) Constructing inhibitory synapses. Nat Rev Neurosci 2:240-250
89. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS (1996) Localization of D4 receptors in GABAergic neurons in primate brain. Nature 381:245-248
90. Nakazawa K, Quirk MC, Chitwood RA, Watanabe M, Yeckel MF, Sun LD, Kato A, Carr CA, Johnston D, Wilson MA, Tonegawa S (2002) Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science 297:211-218
91. Nusser Z, SieghartW, Benke D, Fritschy JM, Somogyi P (1996a) Differential synaptic localization of two major ?-aminobutyric acid type: a receptor ? subunits on hippocampal pyramidal cells. Proc Natl Acad Sci U S A 93:11939-11944
92. Nusser Z, Sieghart W, Stephenson FA, Somogyi P (1996b) The ?6 subunit of the GABAA receptor is concentrated in both inhibitory and excitatory synapses on cerebellar granule cells. J Neurosci 16:103-114
93. Nusser Z, Sieghart W, Somogyi P (1998) Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 18:1693-1703
94. Nutt DJ, Malizia AL (2001) New insights into the role of the GABAA receptor in psychiatric disorders. Brit J Psychiatry 179:390-396
95. Nyri G, Freund TF, Somogyi P (2001) Input-dependent synaptic targeting of ?2 subunit containing GABAA receptors in hippocampal pyramidal cells of the rat. Eur J Neurosci 13:428-442
96. OKeefe J, Recce ML (1993) Phase relationship between hippocampal place units and the EEG theta rhythm. Hippocampus 3:317-330
97. Olsen RW, DeLorey TM, Gordey M, Kang MH (1999) GABA receptor function and epilepsy. Adv Neurol 79:499-510
98. Paulsen O, Moser EI (1998) A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci 21:273-278
99. Pawelzik H, Hughes DI, Thomson AM (2002) Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin- positive interneurons in CA1 of the adult rat hippocampus. J Comp Neurol 443:346-367
100. Penttonen M (1998) Gamma frequency oscillation in the hippocampus of the rat: intracellular analysis in vivo. Eur J Neurosci 10:718-728
101. Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G (2000) GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101:815-850
102. Pitler TA, Alger BE (1992) Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12:4122-4132
103. Pitler TA, Alger BE (1994) Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron 13:1447-1455
104. Riban V, Bouilleret V, Pham-Lé BT, Fritschy JM, Marescaux C, Depaulis A (2002) Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112:101-111
105. Rudolph U, Crestani F, Benke D, Brünig I, Benson J, Fritschy JM, Martin JR, Bluethmann H, Mohler H (1999) Benzodiazepine actions mediated by specific ?-aminobutyric acid A receptor subtypes. Nature 401:796-800
106. Rudolph U, Crestani F, Möhler H (2001) GABAA receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 22:188-194
107. Sanger DJ, Morel E, Perrault G (1996) Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmacol 313:35-42
108. Sarter M, Bruno JP, Berntson GG (2001) Psychotogenic properties of benzodiazepine receptor inverse agonists. Psychopharmacology (Berl) 156:1-13
109. Sasso-Pognetto M, Panzanelli P, Sieghart W, Fritschy JM (2000) Co-localization of multiple GABAA receptor subtypes with gephyrin at postsynaptic sites. J Comp Neurol 420:481-498
110. Scatton B, Depoortere H, George P, Sevrin M, Benavides J, Schoemaker H, Perrault (2000) Selectivity for GABAA receptor ? subunits as a strategy for developing hypnoselective and anxioselective drugs. Int J Neuropsychopharmacol 3:S41.3
111. Sieghart W, Sperk G (2002) Subunit composition, distribution and function of GABAA receptor subtypes. Curr Top Med Chem 2:795-816
112. SingerW, Gray CM (1995) Visual feature integration and the temporal correlation hypothesis. Annu Rev Neurosci 18:555-586
113. Skaggs WE, McNaughton BL, Wilson MA, Barnes CA (1996) Theta phase precession in hippocampal neuronal populations and the compression of temporal sequences. Hippocampus 6:149-172
114. Snead OC, Depaulis A, Vergues M, Marescaux C (1999) Absence epilepsy: advances in experimental animal models. Adv Neurol 79:253-278
115. Stein V, Nicoll RA (2003) GABA generates excitement. Neuron 37:375-378
116. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ (1999) Genetic enhancement of learning and memory in mice. Nature 401:63-69
117. Tia S, Wang JF, Kotchabhakdi N, Vicini S (1996) Distinct deactivation and desensitization kinetics of recombinant GABAA receptors. Neuropharmacology 35:1375-1382
118. Tiihonen J, Kuikka J, Rasanen P, Lepola U, Koponen H, Liuska A, Lehmusvaara A, Vainio P, Kononen M, Bergstrom K, Yu M, Kinnunen I, Akerman K, Karhu J (1997) Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorders: a fractal analysis. Mol Psychiatry 6:463-471
119. Traub RD, Whittington MA, Stanford IM, Jefferys JG (1996) Amechanism for generation of long-range synchronous fast oscillations in the cortex. Nature 383:621-624
120. Traub RD, Draguhn A, Whittington MA, Baldeweg T, Bibbig A, Buhl EH, Schmitz D (2002) Axonal gap junctions between principal neurons: a novel source of network oscillations, and perhaps epileptogenesis. Rev Neurosci 13:1-30
121. Treimann DM (2001) GABAergic mechanisms in epilepsy. Epilepsia 42:8-12
122. Tsien JZ, Huerta PT, Tonegawa S (1996) The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327-1338
123. Vicini S, Ferguson C, Prybylowski K, Kralic J, Morrow AL, Homanics GE (2001) GABAA receptor ?1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J Neurosci 21:3009-3016
124. Vincent P, Marty A (1993) Neighboring cerebellar Purkinje cell communicate via retrograde inhibition of common presynaptic interneurons. Neuron 11:885-893
125. VolkDW, Fritschy JM, Pierri JN, Auh S, Sampson AR, LewisDA (2002) Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 12:1063-1070
126. Wallace RH, Marini C, Petrou S, Harkin LA, Bowser DN, Panchal RG, Williams DA, Sutherland GR, Mulley JC, Scheffer IE, Berkovic SF (2001) Mutant GABAA receptor ?2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28:49-52
127. Weiller E, Bisserbe JC, Maier W, Lecrubier Y (1998) Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care. Br J Psychiatry Suppl 173:18-23
128. Whiting P, Wafford KA, McKernanRM (2000) Pharmacologic subtypes of GABAA receptors based on subunit composition. In: Martin DL, Olsen RW (eds) GABA in the nervous system: the view at fifty years. Lippincott, Philadelphia, pp 113-126
129. Whiting PJ (2003) GABAA receptor subtypes in the brain: a paradigmfor CNS drug discovery? Drug Discov Today 8:445-450
130. Whittington MA, Traub RD, Jeffreys JG (1995) Synchronized oscillations in interneuron network driven by metabotropic glutamate receptor activation. Nature 373:612-615
131. Whittington MA, Traub RD, Faulkner HJ, Stauford IM, Jeffreys JG (1997) Recurrent excitatory postsynaptic potentials induced by synchronized fast cortical oscillations. Proc Natl Acad Sci U S A 94:12198-12203
132. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. [Erratum appears in Nature 2001 Jun 21;411 (6840) :974]. Nature 410:588-592
133. WooTU, Whitehead RE, Melchitzky DS, JewisDA (1998) Asubclass of prefrontalGABAaxon terminals are selectively altered in schizophrenia. ProcNatl Acad Sci U S A 95:5341-5346
134. ZhangY, PerezVelazquez JL, Tian GF, Wu CP, Skinner FK, Caslen PL, Zhang L (1998) Slowoscillations (1 Hz) mediated by GABAergic interneuronal networks in rat hippocampus. J Neurosci 18:9256-9268